Cargando…
Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631692/ https://www.ncbi.nlm.nih.gov/pubmed/35468623 http://dx.doi.org/10.1182/bloodadvances.2022007753 |
_version_ | 1784823870204674048 |
---|---|
author | Abou-Ismail, Mouhamed Yazan Kanack, Adam J. Splinter, Noah P. Smock, Kristi J. Moser, Karen A. Padmanabhan, Anand |
author_facet | Abou-Ismail, Mouhamed Yazan Kanack, Adam J. Splinter, Noah P. Smock, Kristi J. Moser, Karen A. Padmanabhan, Anand |
author_sort | Abou-Ismail, Mouhamed Yazan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9631692 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-96316922022-11-04 Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT Abou-Ismail, Mouhamed Yazan Kanack, Adam J. Splinter, Noah P. Smock, Kristi J. Moser, Karen A. Padmanabhan, Anand Blood Adv Research Letter American Society of Hematology 2022-09-20 /pmc/articles/PMC9631692/ /pubmed/35468623 http://dx.doi.org/10.1182/bloodadvances.2022007753 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://www.ncbi.nlm.nih.gov/pmc/pmcdoc/tagging-guidelines/article/tags.html#el-licenseThis article is made available via the PMC Open Access Subset for unrestricted reuse and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | Research Letter Abou-Ismail, Mouhamed Yazan Kanack, Adam J. Splinter, Noah P. Smock, Kristi J. Moser, Karen A. Padmanabhan, Anand Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT |
title | Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT |
title_full | Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT |
title_fullStr | Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT |
title_full_unstemmed | Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT |
title_short | Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT |
title_sort | safety of bnt162b2 mrna vaccine booster in the setting of ad26.cov2.s-associated vitt |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631692/ https://www.ncbi.nlm.nih.gov/pubmed/35468623 http://dx.doi.org/10.1182/bloodadvances.2022007753 |
work_keys_str_mv | AT abouismailmouhamedyazan safetyofbnt162b2mrnavaccineboosterinthesettingofad26cov2sassociatedvitt AT kanackadamj safetyofbnt162b2mrnavaccineboosterinthesettingofad26cov2sassociatedvitt AT splinternoahp safetyofbnt162b2mrnavaccineboosterinthesettingofad26cov2sassociatedvitt AT smockkristij safetyofbnt162b2mrnavaccineboosterinthesettingofad26cov2sassociatedvitt AT moserkarena safetyofbnt162b2mrnavaccineboosterinthesettingofad26cov2sassociatedvitt AT padmanabhananand safetyofbnt162b2mrnavaccineboosterinthesettingofad26cov2sassociatedvitt |